InvestorsHub Logo
Followers 0
Posts 11
Boards Moderated 0
Alias Born 03/22/2016

Re: hardtogetnewalias post# 3137

Tuesday, 04/26/2016 2:57:41 PM

Tuesday, April 26, 2016 2:57:41 PM

Post# of 4493
Clinical pretrial for the evofosfamide (TH-302) were thought to have failed. Later, observations contradicted there initial results with almost 50%—improvement in the overall survival in Japanese and South Korean patients in the trial.


We have had plenty of good news with the stock but still no rise, I guess we will have to wait for the 1Q results which I think should be in within the next week or 2.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTEM News